hesperetin has been researched along with Atherogenesis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, X; Wu, H; Xu, D; Zou, D | 1 |
| Bennetau-Pelissero, C; Bérard, AM; Chanet, A; Claude, S; Kamran Khan, M; Maier, JA; Mazur, A; Milenkovic, D; Morand, C; Rakotomanomana, N; Shinkaruk, S | 1 |
2 other study(ies) available for hesperetin and Atherogenesis
| Article | Year |
|---|---|
Hesperetin inhibits foam cell formation and promotes cholesterol efflux in THP-1-derived macrophages by activating LXRα signal in an AMPK-dependent manner.
Topics: AMP-Activated Protein Kinase Kinases; Atherosclerosis; Cholesterol; Foam Cells; Hesperidin; Humans; Liver X Receptors; Protein Kinases; THP-1 Cells | 2021 |
Flavanone metabolites decrease monocyte adhesion to TNF-α-activated endothelial cells by modulating expression of atherosclerosis-related genes.
Topics: Atherosclerosis; Cell Adhesion; Endothelial Cells; Flavanones; Gene Expression Profiling; Gene Expression Regulation; Glucuronides; Hesperidin; Human Umbilical Vein Endothelial Cells; Humans; Inflammation; Monocytes; Sulfates; Tumor Necrosis Factor-alpha | 2013 |